1. Home
  2. PNFP vs MDGL Comparison

PNFP vs MDGL Comparison

Compare PNFP & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNFP
  • MDGL
  • Stock Information
  • Founded
  • PNFP 2000
  • MDGL 2011
  • Country
  • PNFP United States
  • MDGL United States
  • Employees
  • PNFP N/A
  • MDGL N/A
  • Industry
  • PNFP Major Banks
  • MDGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNFP Finance
  • MDGL Health Care
  • Exchange
  • PNFP Nasdaq
  • MDGL Nasdaq
  • Market Cap
  • PNFP 7.1B
  • MDGL 6.1B
  • IPO Year
  • PNFP N/A
  • MDGL N/A
  • Fundamental
  • Price
  • PNFP $88.48
  • MDGL $309.91
  • Analyst Decision
  • PNFP Buy
  • MDGL Strong Buy
  • Analyst Count
  • PNFP 12
  • MDGL 9
  • Target Price
  • PNFP $121.75
  • MDGL $420.63
  • AVG Volume (30 Days)
  • PNFP 1.4M
  • MDGL 337.5K
  • Earning Date
  • PNFP 07-15-2025
  • MDGL 08-05-2025
  • Dividend Yield
  • PNFP 1.07%
  • MDGL N/A
  • EPS Growth
  • PNFP 48.26
  • MDGL N/A
  • EPS
  • PNFP 7.51
  • MDGL N/A
  • Revenue
  • PNFP $1,812,787,000.00
  • MDGL $317,383,000.00
  • Revenue This Year
  • PNFP $29.69
  • MDGL $286.17
  • Revenue Next Year
  • PNFP $11.74
  • MDGL $64.17
  • P/E Ratio
  • PNFP $11.98
  • MDGL N/A
  • Revenue Growth
  • PNFP 21.56
  • MDGL N/A
  • 52 Week Low
  • PNFP $81.57
  • MDGL $200.63
  • 52 Week High
  • PNFP $131.91
  • MDGL $377.46
  • Technical
  • Relative Strength Index (RSI)
  • PNFP 22.89
  • MDGL 45.47
  • Support Level
  • PNFP $86.00
  • MDGL $286.44
  • Resistance Level
  • PNFP $93.28
  • MDGL $302.00
  • Average True Range (ATR)
  • PNFP 3.92
  • MDGL 14.02
  • MACD
  • PNFP -3.26
  • MDGL -4.18
  • Stochastic Oscillator
  • PNFP 9.98
  • MDGL 13.35

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: